我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
隶属于 AOBiome Therapeutics, Inc.
相关临床试验
11
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2013
已完成
100.0%
暂无批准数据
- Over 25 companies are developing novel rosacea treatments, indicating a robust pipeline. - Key emerging therapies like Epsolay, M 1220, and BMX-010 are expected to significantly impact the rosacea market. - Sol-Gel Technologies and Maruho Co., Ltd. are among the leading companies in developing advanced-stage rosacea drugs. - Recent regulatory approvals, such as Zydus Lifesciences' metronidazole topical cream, offer new treatment options.
